Company Search:
Advanced Search
Sponsored Links
Merrimack Pharmaceuticals Inc Company Snapshot
Merrimack Pharmaceuticals Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Merrimack Pharmaceuticals Inc with three other companies in this sector in the United States: ImmunoGen, Inc. (2015 sales of $85.54 million of which 100% was Cancer Therapeutics), Vivus, Inc. ($95.43 million of which 100% was Therapeutic Systems), and Raptor Pharmaceutical Corp. ($94.24 million of which 100% was Clinical).

Sales Analysis. During the year ended December of 2015, sales at Merrimack Pharmaceuticals Inc were $89.26 million. This is a decrease of 13.1% versus 2014, when the company's sales were $102.76 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Merrimack Pharmaceuticals Inc
  Stock Performance Chart for Merrimack Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 5.54
(Figures in U.S. Dollars)
1 Week 11.7%   13 Weeks -7.4%  
4 Weeks 0.7%   52 Weeks -42.7%  
Merrimack Pharmaceuticals Inc Key Data:
  Ticker: MACK Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 89,258,000
(Year Ending Jan 2016).
Employees: 230
  Currency: U.S. Dollars Market Cap: 715,994,010
  Fiscal Yr Ends: December Shares Outstanding: 129,240,796
  Share Type: Common Closely Held Shares: 10,709,102
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.